These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37215102)

  • 21. Integrating complement into the molecular pathogenesis of Hidradenitis Suppurativa.
    Grand D; Navrazhina K; Frew JW
    Exp Dermatol; 2020 Jan; 29(1):86-92. PubMed ID: 31688984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications of hidradenitis suppurativa.
    Yuan JT; Naik HB
    Semin Cutan Med Surg; 2017 Jun; 36(2):79-85. PubMed ID: 28538749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/ acne inversa.
    Frew JW; Navrazhina K; Marohn M; Lu PC; Krueger JG
    Exp Dermatol; 2019 Aug; 28(8):886-891. PubMed ID: 31140657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is hidradenitis suppurativa?
    Lee EY; Alhusayen R; Lansang P; Shear N; Yeung J
    Can Fam Physician; 2017 Feb; 63(2):114-120. PubMed ID: 28209676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hidradenitis suppurativa: the role of immune dysregulation.
    Kelly G; Sweeney CM; Tobin AM; Kirby B
    Int J Dermatol; 2014 Oct; 53(10):1186-96. PubMed ID: 24961484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lessons learned from the development of a hidradenitis suppurativa xenograft mouse model.
    Quartey QQ; Miller RJ; Pinsker BL; Okoh UJ; Shipman WD; George BA; Nwizu CC; Barnes LA; Kerns ML; Caffrey JA; Aliu O; Brown ID; Succaria F; Maynard JP; Herbert AS; Kang S; Miller LS; Okoye GA; Byrd AS
    Clin Exp Dermatol; 2020 Mar; 45(2):202-206. PubMed ID: 31322280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hidradenitis suppurativa: current views on epidemiology, pathogenesis, and pathophysiology.
    Micheletti RG
    Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S48-50. PubMed ID: 25188457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hidradenitis Suppurativa and Thyroid Disease: Systematic Review and Meta-Analysis.
    Phan K; Huo YR; Charlton O; Smith SD
    J Cutan Med Surg; 2020; 24(1):23-27. PubMed ID: 31994934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo.
    Campione E; Lanna C; Diluvio L; Cannizzaro MV; Grelli S; Galluzzo M; Talamonti M; Annicchiarico-Petruzzelli M; Mancini M; Melino G; Candi E; Schiavone G; Wang Y; Shi Y; Bianchi L
    Cell Cycle; 2020 Feb; 19(3):257-267. PubMed ID: 31905036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hidradenitis suppurativa in the pediatric population.
    Liy-Wong C; Pope E; Lara-Corrales I
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis.
    Goldburg SR; Strober BE; Payette MJ
    J Am Acad Dermatol; 2020 May; 82(5):1045-1058. PubMed ID: 31604104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hidradenitis Suppurativa: Causes, Features, and Current Treatments.
    Vinkel C; Thomsen SF
    J Clin Aesthet Dermatol; 2018 Oct; 11(10):17-23. PubMed ID: 30519375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on the pathogenesis of hidradenitis suppurativa: implications for therapy.
    Negus D; Ahn C; Huang W
    Expert Rev Clin Immunol; 2018 Apr; 14(4):275-283. PubMed ID: 29509041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiologic and clinical features of hidradenitis suppurativa.
    Parulkar I; Haleem H; Paek SY
    Semin Cutan Med Surg; 2017 Jun; 36(2):42-46. PubMed ID: 28538742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proceeding report of the Fourth Symposium on Hidradenitis Suppurativa Advances 2019.
    Narla S; Price KN; Sachdeva M; Shah M; Shi V; Hamzavi I; Alavi A; Lowes MA
    J Am Acad Dermatol; 2021 Jan; 84(1):120-129. PubMed ID: 32497690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acne and hidradenitis suppurativa.
    Pink A; Anzengruber F; Navarini AA
    Br J Dermatol; 2018 Mar; 178(3):619-631. PubMed ID: 29380349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-standing refractory hidradenitis suppurativa responded to a brodalumab monotherapy in a patient with psoriasis: A possible involvement of Th17 across the spectrum of both diseases.
    Yoshida Y; Oyama N; Iino S; Shimizu C; Hasegawa M
    J Dermatol; 2021 Jun; 48(6):916-920. PubMed ID: 33609416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CME Dermatology 23: Hidradenitis suppurativa].
    Dahmen RA; Lautenschlager S
    Praxis (Bern 1994); 2021; 110(7):363-372. PubMed ID: 34019444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What's Race Got to Do With It? CRP Levels in Immune Mediated Skin Diseases: Considerations for Hidradenitis Suppurativa.
    Okeke CAV; Williams JP; Iwuala CU; Igwe PK; Khanna R; Perry JD; Okoye GA; Byrd AS
    Front Immunol; 2022; 13():847050. PubMed ID: 35432388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.
    Vossen ARJV; van der Zee HH; Prens EP
    Front Immunol; 2018; 9():2965. PubMed ID: 30619323
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.